ATE490469T1 - Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden - Google Patents

Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden

Info

Publication number
ATE490469T1
ATE490469T1 AT04748820T AT04748820T ATE490469T1 AT E490469 T1 ATE490469 T1 AT E490469T1 AT 04748820 T AT04748820 T AT 04748820T AT 04748820 T AT04748820 T AT 04748820T AT E490469 T1 ATE490469 T1 AT E490469T1
Authority
AT
Austria
Prior art keywords
growth
cnp
plasma
assessment
provides
Prior art date
Application number
AT04748820T
Other languages
English (en)
Inventor
Timothy Charles Ramsey Prickett
Eric Arnold Espiner
Arthur Mark Richards
Timothy Grant Yandle
Michael Gary Nicholls
Original Assignee
Otago Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otago Innovation Ltd filed Critical Otago Innovation Ltd
Application granted granted Critical
Publication of ATE490469T1 publication Critical patent/ATE490469T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
AT04748820T 2003-06-17 2004-06-17 Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden ATE490469T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ52652603 2003-06-17
PCT/NZ2004/000125 WO2004111653A1 (en) 2003-06-17 2004-06-17 Assessment of skeletal growth using measurements of nt-cnp peptides

Publications (1)

Publication Number Publication Date
ATE490469T1 true ATE490469T1 (de) 2010-12-15

Family

ID=33550523

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04748820T ATE490469T1 (de) 2003-06-17 2004-06-17 Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden

Country Status (7)

Country Link
US (1) US7919255B2 (de)
EP (1) EP1644740B1 (de)
AT (1) ATE490469T1 (de)
CA (1) CA2570398C (de)
DE (1) DE602004030342D1 (de)
DK (1) DK1644740T3 (de)
WO (1) WO2004111653A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070037208A1 (en) * 2003-05-29 2007-02-15 Foote Robert S Method for detecting cardiac ischemia via changes in b-natriuretic peptide levels
DK3404102T3 (da) 2004-04-21 2021-09-06 Alexion Pharma Inc Knogletilførselskonjugater og fremgangsmåde til anvendelse heraf til målretning af proteiner mod knogle
US8735142B2 (en) * 2005-08-16 2014-05-27 Chipotle Business Group, Inc. Systems and methods for immunosorbent assays for single and multiple analytes
US7767404B2 (en) * 2005-08-16 2010-08-03 Chipotle Business Group, Inc. Apparatus and method for single-step immunosorbent assay for single and multiple analytes
EP3175863B1 (de) 2009-05-20 2021-12-01 BioMarin Pharmaceutical Inc. Varianten des natriuretischen peptids typ c
US9266939B2 (en) 2010-12-27 2016-02-23 Alexion Pharmaceuticals, Inc. Compositions comprising natriuretic peptides and methods of use thereof
US10052366B2 (en) 2012-05-21 2018-08-21 Alexion Pharmaceuticsl, Inc. Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
EP2883060B1 (de) * 2012-08-13 2018-03-21 Otago Innovation Limited Nt-procnp als biomarker für gefässerkrankungen und schwangerschaftskomplikationen
US10822596B2 (en) 2014-07-11 2020-11-03 Alexion Pharmaceuticals, Inc. Compositions and methods for treating craniosynostosis
JP6787894B2 (ja) 2014-12-05 2020-11-18 アレクシオン ファーマシューティカルズ， インコーポレイテッド 組換えアルカリホスファターゼを用いた発作の処置
CA2973883A1 (en) 2015-01-28 2016-08-04 Alexion Pharmaceuticals, Inc. Methods of treating a subject with an alkaline phosphatase deficiency
CN108350440A (zh) 2015-08-17 2018-07-31 阿雷克森制药公司 碱性磷酸酯的制造
EP3355904A4 (de) 2015-09-28 2019-06-12 Alexion Pharmaceuticals, Inc. Identifizierung wirksamer dosierungsschemata für gewebeunspezifische alkalische phosphatase-enzymersatztherapie von hypophosphatasie
WO2017074466A1 (en) 2015-10-30 2017-05-04 Alexion Pharmaceuticals, Inc. Methods for treating craniosynostosis in a patient
US11065306B2 (en) 2016-03-08 2021-07-20 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in children
US10898549B2 (en) 2016-04-01 2021-01-26 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in adolescents and adults
MX2018011833A (es) 2016-04-01 2019-02-13 Alexion Pharma Inc Tratamiento para la debilidad muscular con fosfatasas alcalinas.
WO2017214130A1 (en) 2016-06-06 2017-12-14 Alexion Pharmaceuticals, Inc. Metal impact on manufacturing of alkaline phosphatases
US20170363620A1 (en) 2016-06-17 2017-12-21 Abbott Laboratories BIOMARKERS TO PREDICT NEW ONSET HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF)
EP3500289A4 (de) 2016-08-18 2020-05-06 Alexion Pharmaceuticals, Inc. Verfahren zur behandlung von tracheobronchomalazie
CA3057502A1 (en) 2017-03-31 2018-10-04 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia (hpp) in adults and adolescents
JP2021519590A (ja) 2018-03-30 2021-08-12 アレクシオン ファーマシューティカルズ， インコーポレイテッド 糖タンパク質の製造

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT407580B (de) * 1999-08-20 2001-04-25 Biomedica Gmbh Indikatorpeptid zur diagnose und/oder vorhersage von cardiovasculären und/oder endothelialen erkrankungen, antikörperzusammensetzung und immunoassay
US20030219734A1 (en) * 2001-04-13 2003-11-27 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use

Also Published As

Publication number Publication date
EP1644740A1 (de) 2006-04-12
DE602004030342D1 (de) 2011-01-13
WO2004111653A1 (en) 2004-12-23
US20070292966A1 (en) 2007-12-20
CA2570398A1 (en) 2004-12-23
EP1644740B1 (de) 2010-12-01
US7919255B2 (en) 2011-04-05
EP1644740A4 (de) 2007-12-12
CA2570398C (en) 2020-05-12
DK1644740T3 (da) 2011-02-21

Similar Documents

Publication Publication Date Title
ATE490469T1 (de) Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden
US7344626B2 (en) Method and apparatus for detection of abnormal traces during electrochemical analyte detection
Kumari et al. A nonlinear relationship of generalized and central obesity with diurnal cortisol secretion in the Whitehall II study
NO20063816L (no) Systemer og fremgangsmater for avfoling av blodglykose
Hosoi et al. Quantitative analysis of calcium-dependent vesicle recruitment and its functional role at the calyx of Held synapse
Sargent et al. Rapid vesicular release, quantal variability, and spillover contribute to the precision and reliability of transmission at a glomerular synapse
Shetty et al. Developmental validation of a point-of-care, salivary α-amylase biosensor
Daniels et al. Serial measurement of N-terminal pro–B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA)
CA2535833A1 (en) Method and apparatus for assay of electrochemical properties
NO20045129L (no) System og fremgangsmate for maling av blodglukose
CN102770763B (zh) 电化学分析中的电容检测
EP1664783A4 (de) Schnelltest für glykiertes albumin
EP2042865A3 (de) Systeme und Verfahren zur Unterscheidung zwischen einer Kontrolllösung und einer physiologischen Probe
RU2012103000A (ru) Способ и система для тестирования аналита
CN104838258A (zh) 用于血细胞比容校正的方法和为此适配的血糖仪
CN104582568A (zh) 用于检测使用过且变干的传感器的***和方法
MX340856B (es) Sistema y metodos que determinan concentracion de analito utilizando amperometria resuelta en tiempo.
MXPA02010106A (es) Determinacion de suficiencia de volumen de muestra en dispositivos biosensores.
TW200413718A (en) Method and system for determining the acceptability of signal data collected from a prothrombin time test strip
Kang et al. Reliable clinical serum analysis with reusable electrochemical sensor: Toward point-of-care measurement of the antipsychotic medication clozapine
JP2000275163A5 (ja) 粒子分析装置および自動粒子分析方法
Mason et al. The interpretation of current-clamp recordings in the cell-attached patch-clamp configuration
MX2012007009A (es) Método para diagnosticar un tumor maligno.
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
Bordey et al. Chemokine modulation of high‐conductance Ca2+‐sensitive K+ currents in microglia from human hippocampi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties